Aptevo Therapeutics APVO
NASDAQ APVO
$1.82 -0.04 (-2.15%)
At close: Sep 30, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Other financing activities (2016 - 2021)

Updated

Aptevo Therapeutics (APVO) recorded Other financing activities of $35 million in FY2021.

Analysis

Aptevo Therapeutics (APVO) Other financing activities (2016 - 2021) Analysis & Trends

  • Annual Other financing activities has a five-year compound annual growth rate of 77.9% (FY2016 to FY2021).
  • The FY2021 figure is the lowest annual Other financing activities since FY2017.
  • Per Business Quant data, APVO's Other financing activities was -$10 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Aptevo Therapeutics 2.58 Mn -64.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 35.00 Mn
Dec 31, 2017 -10.15 Mn
Dec 31, 2016 2.36 Mn
API Access

Aptevo Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=APVO&period=max&api_key=YOUR_API_KEY